ARS Pharmaceuticals, Inc
Stock Chart, Company Information, and Scan Results
$5.75(as of Jul 27, 3:59 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
ARS Pharmaceuticals, Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$5.75
Ticker SymbolSPRY
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees154
CountyUSA
Market Cap$589.9M
EBIDTA-200.9M
P/E Ratio0.00
Forward P/E Ratio0.00
Earnings per Share-2.00
Profit Margin0.00%
RSI23.99
Shares Outstanding99.3M
ATR0.54
52-Week High18.50
Volume1,813,459
52-Week Low5.62
Book Value0.0M
P/B Ratio0.00
Upper Keltner8.59
P/S Ratio0.00
Lower Keltner6.16
Next Earnings Date08/12/2026
Cash Surplus0.0M
Next Ex-Dividend DateUnknown
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
ARS Pharmaceuticals, Inc In Our Stock Scanner
As of Jul 27, 2026
Scan Name: 52-Week LowScan Type: Stock Fundamentals
As of ---
Scan Name: Undervalued Blue ChipsScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.